The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.